Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children.

Richard F HowardTatjana RadicMelanie SohnsMariëlle Eerdekens Andrea Waßmuth

Published in: Journal of pain research (2020)

Tapentadol PR was well tolerated and equivalent to morphine PR for both efficacy and safety in children (6 to <18 years old) requiring long-term treatment with opioids.

Keyphrases

chronic pain
young adults
spinal cord injury
replacement therapy